Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

CUSIP: 08205P209

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
35,393,481
Total 13F shares
22,685,530
Share change
+1,440,314
Total reported value
$265,306,276
Price per share
$11.70
Number of holders
56
Value change
+$16,737,178
Number of buys
37
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 08205P209?
CUSIP 08205P209 identifies BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) as of Q2 2025

As of 30 Jun 2025, Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,685,530 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Nantahala Capital Management, LLC, BlackRock, Inc., INFINITUM ASSET MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Schonfeld Strategic Advisors LLC. This page lists 56 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.